La Jolla, CA · Founded 2017 · Privately Held (backing)
Developer of a nerve illumination technology designed to help doctors perform precision surgery. Alume Biosciences is based in La Jolla, CA and was founded in 2017. Its last reported valuation was $128 million in Jan 2023. It has raised $31.2 million across 6 recorded rounds; the latest was a $2.2 million seed round in Mar 2026.
Last reported valuation
$127.8M
Oct 2026
Priced at
—
Total raised
$31.2M
Last round
Seed Round
Mar 2026
Cap table — not yet on record
Alume Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Alume Biosciences with a free account
·Watch Alume Biosciences: the Monday email on marks, rounds and moves
Where does Alume Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Alume Biosciences's 6 recorded funding rounds.
